Retinal laser therapy assessed with adaptive optics imaging

New publication in Medicine

A team of ophthalmologists in Bucharest, Romania, investigated a laser therapy for treating central serous chorioretinopathy. In order to evaluate the impact at the level of retinal cells 6+ months after providing the treatment, they examined the patients’ eyes with an rtx1™ adaptive optics retinal camera.

“Photoreceptor density was considerably lower in affected eyes compared with healthy eyes at all distances from the center of the fovea”.

Additionally, in most patients under study, adaptive optics images revealed multiple microscopic lesions in the photoreceptor cell mosaic, which were invisible with other imaging techniques including fundus autofluorescence.

Click here to read the article in Medicine

Click here to discover the rtx1 Adaptive Optics Retinal Camera

Article reference: Ochinciuc, R. et al. Photoreceptor assessment in focal laser-treated central serous chorioretinopathy using adaptive optics and fundus autofluorescence. Medicine (2020) 99, e19536.